(Q43611757)

English

Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine

scientific article published on 19 February 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

A Tomovici

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

L Barreto

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

P Zickler

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

W Meekison

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

F Noya

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

T Voloshen

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

P Lavigne

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

19 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

2647-2653

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

The science and fiction of the "resurgence" of pertussis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.013

7 January 2021

Pertussis outbreak in primary and secondary schools in Ludwigslust, Germany demonstrating the role of waning immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.013

7 January 2021

Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.013

7 January 2021

Infant and maternal risk factors for pertussis-related infant mortality in the United States, 1999 to 2004.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.013

7 January 2021

Infant pertussis: who was the source?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.013

7 January 2021

Pertussis sources of infection and routes of transmission in the vaccination era.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.013

7 January 2021

Prospective Multinational Study of Pertussis Infection in Hospitalized Infants and Their Household Contacts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.013

7 January 2021

Transmission of Bordetella pertussis to young infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.013

7 January 2021

Pertussis hospitalizations among infants in the United States, 1993 to 2004.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.013

7 January 2021

Pertussis disease burden in the household: how to protect young infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.013

7 January 2021

Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.013

7 January 2021

New Pertussis Vaccination Strategies beyond Infancy: Recommendations by the Global Pertussis Initiative

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.013

7 January 2021

Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.013

7 January 2021

Adult pertussis vaccination strategies and their impact on pertussis in the United States: evaluation of routine and targeted (cocoon) strategies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.013

7 January 2021

Epidemiology of pertussis and Haemophilus influenzae type b disease in Canada with exclusive use of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b pediatric combination vaccine and an adolescent-adult t

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.013

7 January 2021

Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.013

7 January 2021

High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.013

7 January 2021

Immunity to pertussis 5 years after booster immunization during adolescence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.013

7 January 2021

Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.013

7 January 2021

An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.013

7 January 2021

Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.013

7 January 2021

A search for serologic correlates of immunity to Bordetella pertussis cough illnesses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.013

7 January 2021

Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.013

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.02.013

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43611757&oldid=2101889246"